Skip to search boxSkip to navigationSkip to main content

Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2

  • Huanji Zhang
    ,
  • Tong Wang
    ,
  • Kun Zhang
    ,
  • Yu Liu
    ,
  • Feifei Huang
    ,
  • Xinhong Zhu
  • Guangdong Medical College
    ,
  • Sun Yat-Sen University
    ,
  • Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology
    ,
  • Southern Medical University
    ,
  • ,
  • Weil Institute of Critical Care Medicine
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Objective: Inhibition of soluble epoxide hydrolase (Ephx2) has been shown to play a protective role in cardiac hypertrophy, but the mechanism is not fully understood. We tested the hypothesis that deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2. Design: Prospective, controlled, and randomized animal study. Setting: University laboratory. Subjects: Male wild-type C57BL/6 mice and Ephx2 (-/-) mice. Interventions: Male wild-type or Ephx2 (-/-) mice were subjected to transverse aorta constriction surgery. Measurements and Main Results: Four weeks after transverse aorta constriction, Ephx2 (-/-) mice did not develop significant cardiac hypertrophy as that of wild-type mice, indicated by no changes in the ratio of heart weight/body weight and ventricular wall thickness after transverse aorta constriction. Cardiac fibroblast growth factor-2 increased in wild-type-transverse aorta constriction group but this did not change in Ephx2 (-/-)-transverse aorta constriction group, and the serum level of fibroblast growth factor-2 did not change in both groups. In vitro, cardiac fibroblasts were stimulated by angiotensin II to analyze the expression of fibroblast growth factor-2. The effect of increased fibroblast growth factor-2 from cardiac fibroblasts induced by angiotensin II was attenuated by soluble epoxide hydrolase deletion. ERK1/2, p38, and AKT kinase were involved in fibroblast growth factor-2 expression regulated by angiotensin II, and soluble epoxide hydrolase deletion lowered the phosphorylation of ERK1/2 not p38 or AKT to mediate fibroblast growth factor-2 expression. In addition, soluble epoxide hydrolase deletion did not attenuate cardiomyocytes hypertrophy induced by exogenous fibroblast growth factor-2. Conclusions: Our present data demonstrated that deletion of soluble epoxide hydrolase prevented cardiac hypertrophy not only directly to cardiomyocytes but also to cardiac fibroblasts by reducing expression of fibroblast growth factor-2.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages e345-e354

Journal (Volume, Issue Number)

Critical care medicine (Volume 42, Issue 5)

Publication milestones

  • Published - 05/2014

Publication status

Published - 05/2014

ISSN

0090-3493

Publication IDs

  • Scopus: 84899587395
  • PubMed: 24448199

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
0.49
SciVal
Author count
11
SciVal
citations
10
SciVal
Paper percentile
67
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
21
Captures
26